Anaptysbio (ANAB) Receivables - Other (2016 - 2019)

Anaptysbio (ANAB) posted Receivables - Other of $175000.0 for Q1 2019, up 0.57% on a QoQ basis from $174000.0 in Q4 2018, and down 89.13% year-over-year from $1.6 million in Q1 2018.

Anaptysbio (ANAB) Receivables - Other (2016 - 2019) Analysis & Trends

Anaptysbio's Receivables - Other history runs 4 years deep, the most recent figure standing at $175000.0 for Q1 2019.

  • Quarterly Receivables - Other fell 89.13% year-over-year to $175000.0 in Q1 2019, while the trailing twelve-month figure through Mar 2019 was $175000.0 (down 89.13% YoY) and the FY2018 annual result came in at $174000.0, down 89.13% from the prior year.
  • Receivables - Other was $175000.0 for Q1 2019 at Anaptysbio, up from $174000.0 in the prior quarter.
  • Across five years, Receivables - Other topped out at $5.6 million in Q2 2017 and bottomed at $174000.0 in Q4 2018.
  • A 4-year average of $2.0 million and a median of $1.6 million in 2017 frame the typical range for Receivables - Other.
  • Annual changes were most pronounced in 2017 — Receivables - Other sank 61.12% — and 2018, when it tumbled 96.45%.
  • Anaptysbio's Receivables - Other stood at $4.1 million in 2016, then plunged by 61.12% to $1.6 million in 2017, then sank by 89.13% to $174000.0 in 2018, then rose by 0.57% to $175000.0 in 2019.
  • Business Quant data shows ANAB's Receivables - Other at $175000.0 in Q1 2019, $174000.0 in Q4 2018, and $200000.0 in Q3 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Anaptysbio 1.58 Bn 1.29 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2019 175,000.00
Mar 31, 2019 175,000.00
Dec 31, 2018 174,000.00
Dec 31, 2018 174,000.00
Sep 30, 2018 200,000.00
Sep 30, 2018 200,000.00
Jun 30, 2018 200,000.00
Jun 30, 2018 200,000.00
Mar 31, 2018 1.61 Mn
Mar 31, 2018 1.61 Mn
Dec 31, 2017 1.60 Mn
Dec 31, 2017 1.60 Mn
Sep 30, 2017 1.50 Mn
Sep 30, 2017 1.50 Mn
Jun 30, 2017 5.64 Mn
Jun 30, 2017 5.64 Mn
Mar 31, 2017 4.97 Mn
Mar 31, 2017 4.97 Mn
Dec 31, 2016 4.12 Mn
Dec 31, 2016 4.12 Mn